Dr. Michael Potente is an independent research group leader at the Max Planck Institute (MPI) for Heart and Lung Research. He is a trained cardiologist with a primary focus on vascular biology who combines basic science and clinical practice.
Dr. Potente was trained as an MD at the Universities of Frankfurt and Toronto. After obtaining his doctoral degree with honours, he joined the Department of Cardiology at the University of Frankfurt, as it offered the possibility to combine residency with postdoctoral training. He received his board certification in Internal Medicine and Cardiology in 2011 and was appointed as senior physician in the same year. In 2012, he received an independent Max Planck Research Group, which was established at the MPI in Bad Nauheim.
Research in his laboratory is supported by national and international funding organizations such as the Max Planck Society, the Deutsche Forschungsgemeinschaft, the Fondation Leducq, and the European Research Council. He has received several prestigious awards for his scientific work including the Louis N. and Arnold M. Katz Basic Research Prize from the American Heart Association as well as the Albert Fraenkel Prize granted by the German Cardiac Society. In 2014, he was selected for the Young Investigator Programme of the European Molecular Biology Organisation (EMBO).
His current work focuses on metabolic adaptations in endothelial cells, aiming to understand how changes in endothelial metabolic state impact vascular homeostasis and disease.